BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24939242)

  • 41. The experience of phantom limb pain in patients with combat-related traumatic amputations.
    Ketz AK
    Arch Phys Med Rehabil; 2008 Jun; 89(6):1127-32. PubMed ID: 18503810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phantom limb pain after amputation in diabetic patients does not differ from that after amputation in nondiabetic patients.
    Clark RL; Bowling FL; Jepson F; Rajbhandari S
    Pain; 2013 May; 154(5):729-732. PubMed ID: 23433944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?
    Pickering G; Engelen S; Stupar M; Ganry H; Eerdekens M
    J Pain Res; 2024; 17():1327-1344. PubMed ID: 38560405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Virtual Reality Intervention for the Treatment of Phantom Limb Pain: Development and Feasibility Results.
    Rutledge T; Velez D; Depp C; McQuaid JR; Wong G; Jones RCW; Atkinson JH; Giap B; Quan A; Giap H
    Pain Med; 2019 Oct; 20(10):2051-2059. PubMed ID: 31165893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mirror therapy for phantom limb and stump pain: a randomized controlled clinical trial in landmine amputees in Cambodia.
    Ol HS; Van Heng Y; Danielsson L; Husum H
    Scand J Pain; 2018 Oct; 18(4):603-610. PubMed ID: 30207289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
    Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
    Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phantom limb pain: a nursing perspective.
    Virani A; Green T; Turin TC
    Nurs Stand; 2014 Sep; 29(1):44-50. PubMed ID: 25182922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.
    Giménez-Milà M; Videla S; Navarro MA; Faulí A; Ojeda A; Bogdanovich A; Moreno LA; Hernández-Cera C; Busquets C
    BMC Anesthesiol; 2014; 14():120. PubMed ID: 25580085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
    Hansson P; Jensen TS; Kvarstein G; Strömberg M
    Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterisation of Phantom Limb Pain in Traumatic Lower-Limb Amputees.
    Sugawara AT; Simis M; Fregni F; Battistella LR
    Pain Res Manag; 2021; 2021():2706731. PubMed ID: 34938379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ten-year phantom limb pain with only four sessions of Fu's subcutaneous needling: A case report and systematic review.
    Huang H; Yu Y; Peng Y; Fu Z
    Explore (NY); 2024; 20(4):513-519. PubMed ID: 38008590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of mirror therapy in phantom limb pain: a literature review.
    Campo-Prieto P; Rodríguez-Fuentes G
    Neurologia (Engl Ed); 2022 Oct; 37(8):668-681. PubMed ID: 36195376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current Understanding of Phantom Pain and its Treatment.
    Culp CJ; Abdi S
    Pain Physician; 2022 Oct; 25(7):E941-E957. PubMed ID: 36288580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Individual differences in response to phantom limb movement therapy.
    McAvinue LP; Robertson IH
    Disabil Rehabil; 2011; 33(23-24):2186-95. PubMed ID: 21446854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. P300-amplitudes in upper limb amputees with and without phantom limb pain in a visual oddball paradigm.
    Karl A; Diers M; Flor H
    Pain; 2004 Jul; 110(1-2):40-8. PubMed ID: 15275750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcitonin in phantom limb pain: a double-blind study.
    Jaeger H; Maier C
    Pain; 1992 Jan; 48(1):21-27. PubMed ID: 1738570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population.
    Hall GC; Morant SV; Carroll D; Gabriel ZL; McQuay HJ
    BMC Fam Pract; 2013 Feb; 14():28. PubMed ID: 23442783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prospective study of prevalence and risk factors for painful phantom limb in the immediate postoperative period of patients undergoing amputation for chronic arterial ischemia].
    Alamo Tomillero F; Rodríguez de la Torre R; Caba Barrientos F; Hachero Torrejón A; Echevarría Moreno M; García García A; Rodríguez Rodríguez R
    Rev Esp Anestesiol Reanim; 2002; 49(6):295-301. PubMed ID: 12353406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain and spinal stimulation therapies for phantom limb pain: a systematic review.
    Corbett M; South E; Harden M; Eldabe S; Pereira E; Sedki I; Hall N; Woolacott N
    Health Technol Assess; 2018 Nov; 22(62):1-94. PubMed ID: 30407905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.